drugset / Trial / NCT01090505

Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

NCT01090505 ↗

Phase 2 Unknown 160 enrolled Chinese PLA General Hospital
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether S-1 and oxaliplatin as neoadjuvant chemotherapy may improve survival benefit compared with control.

Timeline

Start
2009-11
Primary completion
2012-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule 130 mg/m2 —
Subject S-1 Small molecule 80 mg/m2 —

Indications